Social Anxiety Disorder: Symptoms, CBT, Exposure Therapy and Medication

Evidence reviewed: 8 November 2026. Social anxiety disorder (SAD, sometimes called social phobia) causes persistent fear of being judged, embarrassed, rejected or negatively evaluated in social or performance situations. It can make speaking in meetings, attending classes, eating in public, meeting people or participating in everyday conversations extremely difficult. The condition involves more than ordinary shyness and can cause significant avoidance and impairment. It is treatable, and the NICE guideline CG159 recommends individual cognitive behavioral therapy (CBT) specifically designed for social anxiety as the preferred initial treatment for many adults, with appropriately selected SSRIs as another evidence-based option [1–3].

How does social anxiety disorder differ from shyness?

Many people feel nervous before a presentation or unfamiliar event. Social anxiety disorder involves marked fear that is persistent, disproportionate to the actual social threat and associated with meaningful distress, avoidance or reduced functioning. Symptoms generally persist for at least six months, although the clinical history and developmental context matter [1].

A person may avoid speaking up at work, fail examinations because they cannot participate, refuse opportunities or experience severe anticipatory distress for days before an event. The goal of care is to improve freedom of action and quality of life, not to require everyone to become extroverted.

Symptoms of social anxiety

  • Fear of negative evaluation: worrying that others will notice mistakes, embarrassment or visible anxiety.
  • Avoidance: declining invitations, interviews, classes, meetings or ordinary interactions.
  • Anticipatory anxiety: repeatedly imagining a future social event going badly.
  • Post-event rumination: reviewing conversations and focusing on perceived errors.
  • Physical symptoms: blushing, sweating, trembling, dry mouth, nausea, rapid heartbeat or a shaky voice.
  • Self-focused attention: closely monitoring one’s appearance or performance instead of engaging with the situation.
  • Safety behaviors: rehearsing excessively, avoiding eye contact, using alcohol to cope or speaking as little as possible.

Physical sensations may be intense but are not specific to SAD. Thyroid disease, medication effects, substance use and other anxiety conditions should be considered where relevant. Chest pain, fainting or severe new physical symptoms require appropriate medical assessment, rather than simply being attributed to social anxiety.

Common social anxiety situations

Situation Possible fears or behaviors
Public speaking or presentations Fear of visible trembling, forgetting words or appearing incompetent.
Meetings and classroom discussions Avoiding questions or remaining silent despite knowing an answer.
Meeting new people Fear of saying something awkward, with repeated analysis afterward.
Eating or writing while observed Worry about shaking hands or being watched.
Dating or relationships Avoidance from fear of rejection or embarrassment.
Workplace tasks Turning down interviews, promotions or interactions with supervisors.

Some people chiefly fear performance situations such as public speaking; others experience anxiety across a broad range of interactions. Both require evaluation of severity and functional impact.

What causes social anxiety disorder?

Evidence implicates interacting genetic vulnerability, temperament, learning experiences, social environment, attentional patterns and neural threat-processing systems. Research has studied the amygdala, prefrontal networks and serotonergic pathways, but no single brain abnormality or “serotonin deficit” accounts for every case. A brain scan, blood test or neurotransmitter concentration cannot diagnose SAD [1,2].

Stressful social experiences, bullying or criticism may contribute for some people, but social anxiety can occur without an identifiable traumatic event. The person is not responsible for having the disorder, and treatment does not require blaming family or personality traits.

How is SAD diagnosed?

Assessment explores the feared situations, anticipated judgments, level of avoidance, onset, duration and interference with work, school, relationships or self-care. Clinicians consider other anxiety disorders, depression, autism spectrum conditions, trauma, substance misuse, obsessive-compulsive symptoms and relevant physical illnesses. Co-occurring problems should be addressed, not automatically assumed to be caused by SAD [1].

Measures such as the Social Phobia Inventory (SPIN) or Liebowitz Social Anxiety Scale (LSAS) can support severity tracking and shared treatment planning, but do not replace clinical evaluation. NICE recommends using validated outcome measures throughout treatment to assess progress and guide decisions [1].

First-line treatment: individual CBT designed for social anxiety

NICE CG159 recommends individual CBT based on the Clark and Wells or Heimberg models for adults with SAD. In the Clark and Wells approach, treatment may involve up to 14 sessions of about 90 minutes across approximately four months. The Heimberg model generally involves a comparable structured course [1].

Social anxiety-specific CBT addresses self-focused attention, unhelpful predictions, safety behaviors, distorted mental images and avoidance. Treatment uses behavioral experiments and graded exposure to real-life situations, plus homework and relapse planning. Generic relaxation advice or repeated reassurance does not necessarily deliver the same benefit as a properly structured course.

How exposure and behavioral experiments work

Exposure involves practicing feared but reasonably safe situations without the safety behaviors that maintain anxiety. A therapist collaborates with the patient to make an achievable plan, which may start with asking a simple question and progress toward more challenging conversations or presentations.

For example, a person afraid of sounding foolish might predict that asking a question in class will make everyone laugh. A behavioral experiment tests that prediction, with attention directed toward what actually happens. The goal is not to guarantee that every interaction will be perfect; it is to learn that uncertainty, occasional awkwardness and social feedback can be tolerated without excessive avoidance [1].

Therapy may use video feedback to correct inaccurate self-images and exercises that shift attention from internal monitoring toward other people and the task. Exposure should never involve coerced humiliation or deliberate unsafe social situations.

What if a person does not want in-person CBT?

NICE recommends considering CBT-based supported self-help for adults who decline specialist face-to-face CBT. This may involve structured written or digital material with scheduled professional support. Some services provide evidence-based remote or video-delivered CBT when appropriate. A person should be offered choices and help overcoming accessibility barriers rather than being told their only option is medication [1,2].

Which medicines are recommended?

For adults who decline CBT or prefer pharmacological treatment after an informed discussion, NICE recommends an SSRI—particularly escitalopram or sertraline [1]. These inhibit neuronal serotonin reuptake and can reduce anxiety over time, but they do not produce instant calm. Prescribing depends on age, comorbidities, interactions, local licensing and patient preference.

Treatment Typical role Important considerations
Sertraline Recommended SSRI option for adults who choose medication. GI symptoms, sleep effects and sexual side effects; monitor mood and activation.
Escitalopram Recommended SSRI option according to NICE. Drug interactions, hyponatremia and QT-related caution in selected patients.
Paroxetine or fluvoxamine Alternatives after inadequate response or poor tolerance to initial SSRI. Paroxetine can cause marked withdrawal symptoms; fluvoxamine has significant interactions.
Venlafaxine SNRI alternative when suitable. May affect blood pressure; significant discontinuation symptoms possible.
MAO inhibitors Rare specialist options after multiple treatments fail. Major food, interaction and safety considerations; not routine care.

Some drugs have different approved indications by country. Choosing a medicine requires assessing past treatment, coexisting depression, pregnancy plans, cardiac and hepatic risks, other medications and the patient’s preference.

How long do SSRIs take to work?

SSRIs generally need several weeks before meaningful improvement. NICE recommends reviewing benefit and adverse effects regularly, with formal reassessment after an adequate treatment course. If there is only a partial response to an SSRI after 10–12 weeks, NICE recommends offering individual CBT in addition. If response is inadequate or the medicine poorly tolerated, a clinician may consider an alternative SSRI or venlafaxine [1].

Do not stop medication abruptly or increase the dose without clinician advice. Withdrawal symptoms, symptom return and drug interactions must be addressed with a supervised plan. Improvement should be assessed using real-world participation and quality of life, not only a score or the absence of nervousness before every social event.

Side effects and safety monitoring

SSRIs and SNRIs may cause nausea, sleep changes, headache, sweating and sexual dysfunction. Some patients have initial agitation or worsening anxiety before improvement. Rare but serious complications include serotonin syndrome, hyponatremia and increased bleeding risk with certain medicines. Patients, especially young adults, should be monitored for worsening mood or suicidal thinking after starting or changing antidepressants [1].

Before prescribing, a clinician considers bipolar disorder, medication interactions and suicide risk when relevant. Pregnancy and breastfeeding require individualized risk–benefit assessment; abrupt stopping of effective medicines may also cause harm.

Why benzodiazepines are not routine treatment

NICE advises against routinely offering benzodiazepines, anticonvulsants, tricyclic antidepressants or antipsychotics for SAD in adults [1]. Benzodiazepines may reduce anxiety briefly but carry risks of sedation, impaired coordination, dependence, withdrawal and interference with psychological learning. Long-term use is generally not appropriate for the core disorder.

Alcohol or sedatives should not be used as a strategy to manage social situations. They can increase impairment and reinforce avoidance or dependence. Specialized exceptions in unusual circumstances are separate from routine guideline-based SAD treatment.

What about propranolol for stage fright?

Propranolol, a beta blocker, can reduce peripheral physical symptoms such as tremor and rapid heartbeat in selected people with situational performance anxiety. However, it is not an established first-line treatment for generalized social anxiety disorder, and the evidence for broad long-term SAD symptom improvement is limited [1,2]. It should not replace CBT or an appropriate SSRI when the person has substantial ongoing social anxiety.

Propranolol is unsuitable for some people with asthma, slow heart rate, low blood pressure or certain heart conditions, and can interact with medicines. It requires an appropriate prescriber and should not be casually recommended as an over-the-counter stage-fright remedy.

What if the first treatment does not help?

Before declaring treatment failure, review the diagnosis, therapy quality, medication adherence, adequate trial length, side effects and other conditions. NICE recommends adding CBT after a partial SSRI response, considering an alternative SSRI or venlafaxine after a poor medicine response, and discussing CBT again when medication alone has not been sufficient [1].

Coexisting depression, substance use, trauma or autism-related needs may require adaptations, but should not be assumed to eliminate the benefit of evidence-based anxiety treatment. Complex treatment resistance calls for specialist assessment rather than unmonitored medication combinations.

Social anxiety in children and adolescents

Young people may have severe fear of speaking in class, meeting peers, performing, asking teachers for help or attending school. NICE recommends CBT focused on social anxiety with developmentally appropriate exposure, psychoeducation and selected family involvement [1].

NICE does not recommend routine medication for social anxiety in children and adolescents. Any pharmacotherapy in complex cases requires specialist child and adolescent mental-health assessment, clear consent and safety monitoring, with consideration of local practice and licensing.

Supporting someone with social anxiety

  • Take the distress seriously without treating the person as incapable.
  • Ask what situations are difficult and whether they would welcome help seeking CBT or clinical assessment.
  • Avoid forcing sudden public performances or repeated shaming, which can worsen avoidance.
  • Support gradual, collaborative exposure goals rather than doing all feared tasks for the person.
  • Discuss practical access issues, including remote appointments, schedules and costs.
  • Encourage care for coexisting sleep problems, depression or substance use.

When is urgent help needed?

Social anxiety itself is not usually an emergency, but suicidal thoughts with intent, severe depression, inability to care for oneself, dangerous substance use or immediate safety concerns require urgent support. Contact emergency services or a crisis team if there is imminent risk. People with new chest pain, collapse or severe physical symptoms should not assume the cause is anxiety without medical assessment.

Frequently asked questions

Is social anxiety disorder just shyness?

No. SAD causes persistent disproportionate fear and meaningful impairment in social or performance contexts [1].

What is the best first treatment?

NICE recommends individual, social anxiety-specific CBT based on the Clark and Wells or Heimberg models [1].

Do SSRIs work immediately?

No. Benefits generally develop over several weeks, with careful monitoring and an adequate trial.

Is propranolol a cure for social anxiety?

No. It may help specific physical performance symptoms in selected patients but does not replace evidence-based treatment for broader SAD.

Should benzodiazepines be used every day for SAD?

No. Routine benzodiazepine treatment is discouraged because of safety and dependence concerns [1].

Can CBT be delivered online?

Yes, appropriately designed, therapist-supported or remote CBT may be available, depending on services and individual needs.

Key takeaways

Social anxiety disorder is treatable. Start with a clear diagnosis and individual CBT with exposure and behavioral experiments where available. SSRIs such as sertraline or escitalopram are options for adults who choose medication. Monitor response, avoid routine benzodiazepines, and distinguish situational performance anxiety from persistent generalized social fears.

References

  1. National Institute for Health and Care Excellence. Social anxiety disorder: recognition, assessment and treatment (CG159). NICE; accessed 8 Nov 2026.
  2. National Institute for Health and Care Excellence. Social anxiety disorder: treatments for adults. NICE.
  3. National Institute of Mental Health. Social anxiety disorder: more than just shyness. NIH; accessed 8 Nov 2026.
  4. National Institute for Health and Care Excellence. Social anxiety disorder: interventions for children and young people. NICE.

Medical disclaimer: Educational information only. Diagnosis and psychiatric medication decisions require qualified clinicians. Do not self-prescribe beta blockers, benzodiazepines or antidepressants or stop them abruptly. Seek urgent help for suicidal intent or immediate safety concerns.

Medical & AI Disclaimer

The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.

We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.

Leave a Reply

Your email address will not be published. Required fields are marked *